Study to assess an immune status in small cell lung cancer patients treated with cytotoxic chemotherapy

Not Applicable

Recruiting

• Conditions: small cell lung cancer

• Registration Number: JPRN-UMIN000028301
• Lead Sponsor: Saitama medical university international medical center

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-07-20
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Not provided

Exclusion Criteria

1. The patients who are difficult to entry to this study because of psychological disorders. 2. The patients who are judged to be unsuitable by doctors.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To examine T cell balance with flow cytometry. Samples should be collected at four points, pretreatment, mid-treatment (2 and 3 or 4 weeks) and post-treatment 3 to 4 weeks later.